Browsing by Author Kosmidis, P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 41 to 60 of 75 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)Kosmidis, P.; Mylonakis, N.; Skarlos, D.; Samantas, E.; Dimopoulos, M.; Papadimitriou, C.; Kalophonos, C.; Pavlidis, N.; Nikolaidis, C.; Papaconstantinou, C.; Fountzilas, G.24-Nov-2015-
Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized studyKosmidis, P.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanassiadis, A.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Pectasides, D.; Kalogera-Fountzila, A.; Skarlos, D.; Kalofonos, H. P.; Papadimitriou, C.; Bafaloukos, D.; Lambropoulos, S.; Papadopoulos, S.; Kourea, H.; Markopoulos, C.; Linardou, H.; Mavroudis, D.; Briasoulis, E.; Pavlidis, N.; Razis, E.; Kosmidis, P.; Gogas, H.24-Nov-2015-
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Kalofonos, H. P.; Dafni, U.; Papadimitriou, C.; Bafaloukos, D.; Papakostas, P.; Kalogera-Fountzila, A.; Gogas, H.; Aravantinos, G.; Moulopoulos, L. A.; Economopoulos, T.; Pectasides, D.; Maniadakis, N.; Siafaka, V.; Briasoulis, E.; Christodoulou, C.; Tsavdaridis, D.; Makrantonakis, P.; Razis, E.; Kosmidis, P.; Skarlos, D.; Dimopoulos, M. A.24-Nov-2015-
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Stathopoulos, G.; Nicolaides, C.; Kalogera-Fountzila, A.; Kalofonos, H.; Nikolaou, A.; Bacoyiannis, C.; Samantas, E.; Papadimitriou, C.; Kosmidis, P.; Daniilidis, J.; Pavlidis, N.24-Nov-2015-
Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Athanassiadis, A.; Kalogera-Fountzila, A.; Aravantinos, G.; Bafaloukos, D.; Briasoulis, E.; Dombros, N.; Ioannidis, I.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015-
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Skarlos, D.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Nicolaou, A.; Dombros, N.; Briasoulis, E.; Dinopoulou, M.; Stathopoulos, G.; Pavlidis, N.; Kosmidis, P.; Daniilidis, J.24-Nov-2015-
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancerFountzilas, G.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Briassoulis, E.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015-
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) studyAravantinos, G.; Fountzilas, G.; Kosmidis, P.; Dimopoulos, M. A.; Stathopoulos, G. P.; Pavlidis, N.; Bafaloukos, D.; Papadimitriou, C.; Karpathios, S.; Georgoulias, V.; Papakostas, P.; Kalofonos, H. P.; Grimani, E.; Skarlos, D. V.24-Nov-2015-
Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group studySkarlos, D. V.; Aravantinos, G.; Kosmidis, P.; Athanassiadis, A.; Stathopoulos, G. P.; Pavlidis, N.; Bafaloukos, D.; Karphathios, S.; Papakostas, P.; Bamia, C.; Fountzilas, G.24-Nov-2015-
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancerBriasoulis, E.; Samantas, E.; Kalofonos, H.; Skarlos, D.; Makatsoris, T.; Christodoulou, C.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group StudyPavlidis, N.; Nicolaides, C.; Athanassiadis, A.; Beriatou, K.; Skarlos, D.; Giannakakis, T.; Kosmidis, P.; Karvounis, N.; Fountzilas, G.24-Nov-2015-
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancerAravantinos, G.; Bafaloukos, D.; Fountzilas, G.; Christodoulou, C.; Papadimitriou, C.; Pavlidis, N.; Kalofonos, H. P.; Gogas, H.; Kosmidis, P.; Dimopoulos, M. A.24-Nov-2015-
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Skarlos, D.; Dafni, U.; Gogas, H.; Briasoulis, E.; Pectasides, D.; Papadimitriou, C.; Markopoulos, C.; Polychronis, A.; Kalofonos, H. P.; Siafaka, V.; Kosmidis, P.; Timotheadou, E.; Tsavdaridis, D.; Bafaloukos, D.; Papakostas, P.; Razis, E.; Makrantonakis, P.; Aravantinos, G.; Christodoulou, C.; Dimopoulos, A. M.24-Nov-2015-
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III TrialGogas, H.; Dafni, U.; Karina, M.; Papadimitriou, C.; Batistatou, A.; Bobos, M.; Kalofonos, H. P.; Eleftheraki, A. G.; Timotheadou, E.; Bafaloukos, D.; Christodoulou, C.; Markopoulos, C.; Briasoulis, E.; Papakostas, P.; Samantas, E.; Kosmidis, P.; Stathopoulos, G. P.; Karanikiotis, C.; Pectasides, D.; Dimopoulos, M. A.; Fountzilas, G.24-Nov-2015-
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Zisiadis, A.; Dafni, U.; Konstantaras, C.; Hatzitheoharis, G.; Liaros, A.; Athanassiou, E.; Dombros, N.; Dervenis, C.; Basdanis, G.; Gamvros, O.; Souparis, A.; Briasoulis, E.; Samantas, E.; Kappas, A.; Kosmidis, P.; Skarlos, D.; Pavlidis, N.24-Nov-2015-
Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory studyRazis, E.; Briasoulis, E.; Vrettou, E.; Skarlos, D. V.; Papamichael, D.; Kostopoulos, I.; Samantas, E.; Xanthakis, I.; Bobos, M.; Galanidi, E.; Bai, M.; Gikonti, I.; Koukouma, A.; Kafiri, G.; Papakostas, P.; Kalogeras, K. T.; Kosmidis, P.; Fountzilas, G.24-Nov-2015-
Predictive and Prognostic Significance of Somatic Mutations in the Tyrosine Kinase (Tk) Domain of Egfr in Nsclc Patients Treated with Single Agent Gefitinib: A Systematic Review and Meta-AnalysisMurray, S.; Evangelou, E.; Linardou, H.; Kosmidis, P.; Bafaloukos, D.; Ioannidis, J.24-Nov-2015-
Predictive Significance of Egfr Somatic Mutations and Gene Copy Number in Nsclc Patients Treated with Single Agent Tyrosine Kinase Inhibitors: A Systematic Review and Meta-AnalysisMurray, S.; Evangelou, E.; Linardou, H.; Dahabreh, I. J.; Kosmidis, P.; Bafaloukos, D.; Ioannidis, J. P. A.24-Nov-2015-
Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group studyChristodolou, C.; Pavlidis, N.; Samantas, E.; Fountzilas, G.; Kouvatseas, G.; Pagdatoglou, K.; Palamidas, F.; Nikolaidis, C.; Angelidou, M.; Kalofonos, H. P.; Kosmidis, P.; Skarlos, D. V.24-Nov-2015-